Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin and CBT-I for insomnia in adults with schizophrenia
ACTRN12613000970741Phase 4Terminated
- Sponsor
- The University of Western Australia
- Start
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of melatonin in Insomnia (4 arms), sponsored by The University of Western Australia. Primary endpoints: Reduction in insomnia symptoms and Improvements in sleep. Started Mar 2014; status: terminated.
02
Drugs
melatonin
03
Conditions
Insomnia
Beyond the preview
Go deeper on ACTRN12613000970741.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12613000970741.